Literature DB >> 12603134

Fundamental reaction mechanism for cocaine hydrolysis in human butyrylcholinesterase.

Chang-Guo Zhan1, Fang Zheng, Donald W Landry.   

Abstract

Butyrylcholinesterase (BChE)-cocaine binding and the fundamental pathway for BChE-catalyzed hydrolysis of cocaine have been studied by molecular modeling, molecular dynamics (MD) simulations, and ab initio calculations. Modeling and simulations indicate that the structures of the prereactive BChE/substrate complexes for (-)-cocaine and (+)-cocaine are all similar to that of the corresponding prereactive BChE/butyrylcholine (BCh) complex. The overall binding of BChE with (-)-cocaine and (+)-cocaine is also similar to that proposed with butyrylthiocholine and succinyldithiocholine, i.e., (-)- or (+)-cocaine first slides down the substrate-binding gorge to bind to Trp-82 and stands vertically in the gorge between Asp-70 and Trp-82 (nonprereactive complex) and then rotates to a position in the catalytic site within a favorable distance for nucleophilic attack and hydrolysis by Ser-198 (prereactive complex). In the prereactive complex, cocaine lies horizontally at the bottom of the gorge. The fundamental catalytic hydrolysis pathway, consisting of acylation and deacylation stages similar to those for ester hydrolysis by other serine hydrolases, was proposed on the basis of the simulated prereactive complex and confirmed theoretically by ab initio reaction coordinate calculations. Both the acylation and deacylation follow a double-proton-transfer mechanism. The calculated energetic results show that within the chemical reaction process the highest energy barrier and Gibbs free energy barrier are all associated with the first step of deacylation. The calculated ratio of the rate constant (k(cat)) for the catalytic hydrolysis to that (k(0)) for the spontaneous hydrolysis is approximately 9.0 x 10(7). The estimated k(cat)/k(0) value of approximately 9.0 x 10(7) is in excellent agreement with the experimentally derived k(cat)/k(0) value of approximately 7.2 x 10(7) for (+)-cocaine, whereas it is approximately 2000 times larger than the experimentally derived k(cat)/k(0) value of approximately 4.4 x 10(4) for (-)-cocaine. All of the results suggest that the rate-determining step of the BChE-catalyzed hydrolysis of (+)-cocaine is the first step of deacylation, whereas for (-)-cocaine the change from the nonprereactive complex to the prereactive complex is rate-determining and has a Gibbs free energy barrier higher than that for the first step of deacylation by approximately 4 kcal/mol. A further analysis of the structural changes from the nonprereactive complex to the prereactive complex reveals specific amino acid residues hindering the structural changes, providing initial clues for the rational design of BChE mutants with improved catalytic activity for (-)-cocaine.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12603134      PMCID: PMC2893393          DOI: 10.1021/ja020850+

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  48 in total

Review 1.  Exploiting antibodies as catalysts: potential therapeutic applications.

Authors:  C Tellier
Journal:  Transfus Clin Biol       Date:  2002-01       Impact factor: 1.406

2.  Anticocaine catalytic antibodies have no affinity for RTI compounds: implications for treatment.

Authors:  M J Kuhar; F I Carroll; N Bharat; D W Landry
Journal:  Synapse       Date:  2001-08       Impact factor: 2.562

3.  Conformation gating as a mechanism for enzyme specificity.

Authors:  H X Zhou; S T Wlodek; J A McCammon
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-04       Impact factor: 11.205

4.  A catalytic antibody against cocaine attenuates cocaine's cardiovascular effects in mice: a dose and time course analysis.

Authors:  R J Briscoe; P M Jeanville; C Cabrera; T J Baird; J H Woods; D W Landry
Journal:  Int Immunopharmacol       Date:  2001-06       Impact factor: 4.932

5.  Amino acid residues involved in the interaction of acetylcholinesterase and butyrylcholinesterase with the carbamates Ro 02-0683 and bambuterol, and with terbutaline.

Authors:  Z Kovarik; Z Radić; B Grgas; M Skrinjarić-Spoljar; E Reiner; V Simeon-Rudolf
Journal:  Biochim Biophys Acta       Date:  1999-08-17

6.  Activities of the enantiomers of cocaine and some related compounds as substrates and inhibitors of plasma butyrylcholinesterase.

Authors:  S J Gatley
Journal:  Biochem Pharmacol       Date:  1991-04-15       Impact factor: 5.858

Review 7.  Application of artificial enzymes to the problem of cocaine.

Authors:  P De Prada; G Winger; D W Landry
Journal:  Ann N Y Acad Sci       Date:  2000       Impact factor: 5.691

8.  Participation of cytochromes P4502B and P4503A in cocaine toxicity in rat hepatocytes.

Authors:  T S Poet; C A McQueen; J R Halpert
Journal:  Drug Metab Dispos       Date:  1996-01       Impact factor: 3.922

9.  A computer model of glycosylated human butyrylcholinesterase.

Authors:  C B Millard; C A Broomfield
Journal:  Biochem Biophys Res Commun       Date:  1992-12-30       Impact factor: 3.575

10.  Design and expression of organophosphorus acid anhydride hydrolase activity in human butyrylcholinesterase.

Authors:  C B Millard; O Lockridge; C A Broomfield
Journal:  Biochemistry       Date:  1995-12-12       Impact factor: 3.162

View more
  62 in total

1.  Free energy perturbation simulation on transition states and high-activity mutants of human butyrylcholinesterase for (-)-cocaine hydrolysis.

Authors:  Wenchao Yang; Yongmei Pan; Lei Fang; Daquan Gao; Fang Zheng; Chang-Guo Zhan
Journal:  J Phys Chem B       Date:  2010-08-26       Impact factor: 2.991

2.  Reaction pathway and free energy profiles for butyrylcholinesterase-catalyzed hydrolysis of acetylthiocholine.

Authors:  Xi Chen; Lei Fang; Junjun Liu; Chang-Guo Zhan
Journal:  Biochemistry       Date:  2012-02-03       Impact factor: 3.162

3.  Novel pharmacological approaches to treatment of drug overdose and addiction.

Authors:  Chang-Guo Zhan
Journal:  Expert Rev Clin Pharmacol       Date:  2009       Impact factor: 5.045

4.  Interaction of tyrosine 151 in norepinephrine transporter with the 2β group of cocaine analog RTI-113.

Authors:  Erik R Hill; Xiaoqin Huang; Chang-Guo Zhan; F Ivy Carroll; Howard H Gu
Journal:  Neuropharmacology       Date:  2011-03-21       Impact factor: 5.250

5.  Enzyme-therapy approaches for the treatment of drug overdose and addiction.

Authors:  Fang Zheng; Chang-Guo Zhan
Journal:  Future Med Chem       Date:  2011-01       Impact factor: 3.808

6.  Computational design of a human butyrylcholinesterase mutant for accelerating cocaine hydrolysis based on the transition-state simulation.

Authors:  Daquan Gao; Hoon Cho; Wenchao Yang; Yongmei Pan; Guangfu Yang; Hsin-Hsiung Tai; Chang-Guo Zhan
Journal:  Angew Chem Int Ed Engl       Date:  2006-01-16       Impact factor: 15.336

7.  Hierarchical clustering analysis of flexible GBR 12909 dialkyl piperazine and piperidine analogs.

Authors:  Kathleen M Gilbert; Carol A Venanzi
Journal:  J Comput Aided Mol Des       Date:  2006-07-20       Impact factor: 3.686

8.  Probing structure-function relationships of serine hydrolases and proteases with carbamate and thiocarbamate inhibitors.

Authors:  G Lin; S-Y Chiou; B-C Hwu; C-W Hsieh
Journal:  Protein J       Date:  2006-01       Impact factor: 2.371

Review 9.  Butyrylcholinesterase for protection from organophosphorus poisons: catalytic complexities and hysteretic behavior.

Authors:  Patrick Masson; Oksana Lockridge
Journal:  Arch Biochem Biophys       Date:  2009-12-11       Impact factor: 4.013

Review 10.  Rational design of an enzyme mutant for anti-cocaine therapeutics.

Authors:  Fang Zheng; Chang-Guo Zhan
Journal:  J Comput Aided Mol Des       Date:  2007-11-08       Impact factor: 3.686

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.